CAPR
Price
$11.15
Change
+$0.97 (+9.53%)
Updated
Jun 27 closing price
Capitalization
510.56M
39 days until earnings call
WVE
Price
$6.67
Change
-$0.36 (-5.12%)
Updated
Jun 27 closing price
Capitalization
1.04B
32 days until earnings call
Interact to see
Advertisement

CAPR vs WVE

Header iconCAPR vs WVE Comparison
Open Charts CAPR vs WVEBanner chart's image
Capricor Therapeutics
Price$11.15
Change+$0.97 (+9.53%)
Volume$2.64M
Capitalization510.56M
Wave Life Sciences
Price$6.67
Change-$0.36 (-5.12%)
Volume$2.96M
Capitalization1.04B
CAPR vs WVE Comparison Chart in %
Loading...
CAPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WVE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CAPR vs. WVE commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAPR is a Buy and WVE is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (CAPR: $11.15 vs. WVE: $6.67)
Brand notoriety: CAPR and WVE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CAPR: 87% vs. WVE: 220%
Market capitalization -- CAPR: $510.56M vs. WVE: $1.04B
CAPR [@Biotechnology] is valued at $510.56M. WVE’s [@Biotechnology] market capitalization is $1.04B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CAPR’s FA Score shows that 0 FA rating(s) are green whileWVE’s FA Score has 0 green FA rating(s).

  • CAPR’s FA Score: 0 green, 5 red.
  • WVE’s FA Score: 0 green, 5 red.
According to our system of comparison, CAPR is a better buy in the long-term than WVE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CAPR’s TA Score shows that 6 TA indicator(s) are bullish while WVE’s TA Score has 3 bullish TA indicator(s).

  • CAPR’s TA Score: 6 bullish, 4 bearish.
  • WVE’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, CAPR is a better buy in the short-term than WVE.

Price Growth

CAPR (@Biotechnology) experienced а +34.99% price change this week, while WVE (@Biotechnology) price change was +1.52% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

CAPR is expected to report earnings on Aug 07, 2025.

WVE is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
WVE($1.04B) has a higher market cap than CAPR($511M). CAPR YTD gains are higher at: -19.203 vs. WVE (-46.079). CAPR has higher annual earnings (EBITDA): -55.78M vs. WVE (-117.1M). WVE has more cash in the bank: 243M vs. CAPR (145M). CAPR has less debt than WVE: CAPR (1.25M) vs WVE (23.6M). WVE has higher revenues than CAPR: WVE (105M) vs CAPR (17.4M).
CAPRWVECAPR / WVE
Capitalization511M1.04B49%
EBITDA-55.78M-117.1M48%
Gain YTD-19.203-46.07942%
P/E RatioN/AN/A-
Revenue17.4M105M17%
Total Cash145M243M60%
Total Debt1.25M23.6M5%
FUNDAMENTALS RATINGS
CAPR vs WVE: Fundamental Ratings
CAPR
WVE
OUTLOOK RATING
1..100
7275
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
55
Fair valued
PROFIT vs RISK RATING
1..100
67100
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
4362
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a25

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

WVE's Valuation (55) in the Biotechnology industry is in the same range as CAPR (76). This means that WVE’s stock grew similarly to CAPR’s over the last 12 months.

CAPR's Profit vs Risk Rating (67) in the Biotechnology industry is somewhat better than the same rating for WVE (100). This means that CAPR’s stock grew somewhat faster than WVE’s over the last 12 months.

CAPR's SMR Rating (98) in the Biotechnology industry is in the same range as WVE (98). This means that CAPR’s stock grew similarly to WVE’s over the last 12 months.

CAPR's Price Growth Rating (43) in the Biotechnology industry is in the same range as WVE (62). This means that CAPR’s stock grew similarly to WVE’s over the last 12 months.

CAPR's P/E Growth Rating (100) in the Biotechnology industry is in the same range as WVE (100). This means that CAPR’s stock grew similarly to WVE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CAPRWVE
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
84%
Momentum
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
88%
MACD
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
79%
Advances
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 4 days ago
76%
Declines
ODDS (%)
Bearish Trend 10 days ago
85%
Bearish Trend 13 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
72%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CAPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WVE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSTQX13.320.08
+0.60%
Morningstar US Equity
GSTIX14.270.08
+0.56%
Goldman Sachs Strategic Growth Instl
AILIX12.110.06
+0.50%
Cavanal Hill Hedged Equity Income Instl
CSJRX67.890.12
+0.18%
Cohen & Steers Realty Shares R
CCSMX25.01N/A
N/A
Conestoga SMid Cap Investors

CAPR and

Correlation & Price change

A.I.dvisor tells us that CAPR and SNDX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CAPR and SNDX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CAPR
1D Price
Change %
CAPR100%
+9.53%
SNDX - CAPR
32%
Poorly correlated
-2.80%
WVE - CAPR
32%
Poorly correlated
-5.12%
CORT - CAPR
30%
Poorly correlated
-1.49%
ABEO - CAPR
30%
Poorly correlated
-2.54%
IMNM - CAPR
29%
Poorly correlated
-0.23%
More

WVE and

Correlation & Price change

A.I.dvisor indicates that over the last year, WVE has been loosely correlated with PRQR. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if WVE jumps, then PRQR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WVE
1D Price
Change %
WVE100%
-5.12%
PRQR - WVE
60%
Loosely correlated
-5.56%
KRRO - WVE
53%
Loosely correlated
-3.16%
OCUL - WVE
46%
Loosely correlated
-2.54%
ATNF - WVE
42%
Loosely correlated
-4.27%
KYMR - WVE
41%
Loosely correlated
-3.48%
More